107 / 168
105
(
`
cr)
NOTE 13 NON-CURRENT INVESTMENTS
1
(continued)
As at
March 31, 2015
As at
March 31, 2014
Long-term investments
Face value
2
Number of
shares
c) Investments in Preference
shares
In subsidiary companies
Atul Bioscience Ltd (6% Cumulative
Redeemable Preference shares)
100 2,00,000
2.00
2.00
Atul Bioscience Ltd (10%
Cumulative Redeemable Preference
shares)
100
40,400
0.40
0.40
2.40
2.40
In associate company
Amal Ltd (0% Redeemable Preference
shares) (refer Note 28.13)
10 1,00,00,000
10.00
10.00
B. Other than trade investments
a) Quoted Equity instruments
In others
Arvind Ltd
10 41,27,471
46.64
46.64
BASF India Ltd
10 2,61,396
0.84
0.84
ICICI Bank Ltd
10
19,823
0.14
0.14
Jain Irrigation Systems Ltd
2
4,200
0.02
0.02
Nagarjuna Oil Refinery Ltd
1
31,500
–
–
Novartis India Ltd
5 3,84,660
1.02
1.02
Pfizer Ltd
3
10 9,58,927
1.50
–
Wyeth Ltd
(upto December 11, 2014)
10 (13,69,895)
–
1.50
50.16
50.16
b) Unquoted equity instruments
In others
Nagarjuna Fertilizers and Chemicals
Ltd
1
34,650
0.04
0.04
c) Investments in Government or
Trust securities
6 Years National Savings
Certificates (deposited with the
Government departments)
88,000
0.01
0.01
148.31
136.47
C. Share application money
(Atul Middle East FZ-LLC – subsidiary
company)
0.51
–
148.82
136.47
Particulars
Book value
as at March 31,
Market value
as at March 31,
2015
2014
2015
2014
Quoted
50.20
50.20 376.99 236.15
Unquoted
98.11
86.27
148.31 136.47
Aggregate provision for diminution
2.54
2.52
1
Valued at cost unless otherwise stated |
2
In
`
and fully paid unless otherwise stated |
3
Received upon merger of Wyeth Ltd
Notes
to the Financial Statements